Clinical Research Directory
Browse clinical research sites, groups, and studies.
Remote Ischemic Conditioning With Local Ischemic Postconditioning in High-Risk ST-elevation Myocardial Infarction
Sponsor: Helios Health Institute GmbH
Summary
The RIP-HIGH trial is a two-arm randomized controlled trial aiming to compare the impact of combined remote ischemic conditioning (RIP) and local ischemic postconditioning (PostC) vs. standard of care on clinical outcome in high-risk ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
Official title: Randomized Comparison of Combined Remote Ischemic Conditioning and Local Postconditioning Compared to Standard Treatment in High-risk ST-elevation Myocardial Infarction Patients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
250
Start Date
2021-07-05
Completion Date
2030-07-01
Last Updated
2025-03-13
Healthy Volunteers
No
Conditions
Interventions
RIC + PostC + Standard PCI
RIC by arm ischemia initiated on hospital admission plus local PostC by re-inflating the angioplasty balloon after re-opening the infarct-related artery
Standard PCI
Standard PCI
Locations (11)
Medizinische Universität Innsbruck
Innsbruck, Austria
Klinikum Links der Weser
Bremen, Germany
Herzzentrum Dresden
Dresden, Germany
Universitätsklinikum Düsseldorf
Düsseldorf, Germany
University Hospital Essen
Essen, Germany
University Clinic Hamburg-Eppendorf
Hamburg, Germany
Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology
Leipzig, Germany
Klinikum Ludwigshafen
Ludwigshafen, Germany
University Heart Center Lübeck - University of Schleswig-Holstein
Lübeck, Germany
Universitätsmedizin Rostock
Rostock, Germany
University Hospital Tübingen
Tübingen, Germany